Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Fox

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
American Journal of Medical Genetics. Part A|August 21, 2007
Prenatal detection and outcome of congenital diaphragmatic hernia (CDH) associated with deletion of chromosome 15q26: two patients and review of the literatureM Klaassens, R J H Galjaard, D A Scott, et al.
Bioorganic & Medicinal Chemistry Letters|April 8, 2014
Discovery of dual orexin receptor antagonists with rat sleep efficacy enabled by expansion of the acetonitrile-assisted/diphosgene-mediated 2,4-dichloropyrimidine synthesisAnthony J Roecker, Swati P Mercer, C Meacham Harrell, et al.
Frontiers in Behavioral Neuroscience|June 7, 2014
Orexin receptor antagonist-induced sleep does not impair the ability to wake in response to emotionally salient acoustic stimuli in dogsPamela L Tannenbaum, Joanne Stevens, Jacquelyn Binns, et al.
BMC Neuroscience|September 23, 2014
Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulatorsAnthony L Gotter, Susan L Garson, Joanne Stevens, et al.
JAMA Neurology|March 6, 2013
Parkin disease: a clinicopathologic entity?Karen M Doherty, Laura Silveira-Moriyama, Laura Parkkinen, et al.
Journal of Neurogenetics|April 9, 2011
Promotion of sleep by suvorexant-a novel dual orexin receptor antagonistChristopher J Winrow, Anthony L Gotter, Christopher D Cox, et al.
Neuropharmacology|October 25, 2011
Pharmacological characterization of MK-6096 - a dual orexin receptor antagonist for insomniaChristopher J Winrow, Anthony L Gotter, Christopher D Cox, et al.
Neuropharmacology|July 15, 2009
Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposureChristopher J Winrow, Keith Q Tanis, Duane R Reiss, et al.
Frontiers in Neuroscience|January 9, 2014
Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulatorsAndres D Ramirez, Anthony L Gotter, Steven V Fox, et al.
Journal of Neurogenetics|November 19, 2011
Pharmacological validation of candidate causal sleep genes identified in an N2 crossJoseph I Brunner, Anthony L Gotter, Joshua Millstein, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
American Journal of Medical Genetics. Part A|August 21, 2007
Prenatal detection and outcome of congenital diaphragmatic hernia (CDH) associated with deletion of chromosome 15q26: two patients and review of the literatureM Klaassens, R J H Galjaard, D A Scott, et al.
Bioorganic & Medicinal Chemistry Letters|April 8, 2014
Discovery of dual orexin receptor antagonists with rat sleep efficacy enabled by expansion of the acetonitrile-assisted/diphosgene-mediated 2,4-dichloropyrimidine synthesisAnthony J Roecker, Swati P Mercer, C Meacham Harrell, et al.
Frontiers in Behavioral Neuroscience|June 7, 2014
Orexin receptor antagonist-induced sleep does not impair the ability to wake in response to emotionally salient acoustic stimuli in dogsPamela L Tannenbaum, Joanne Stevens, Jacquelyn Binns, et al.
BMC Neuroscience|September 23, 2014
Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulatorsAnthony L Gotter, Susan L Garson, Joanne Stevens, et al.
JAMA Neurology|March 6, 2013
Parkin disease: a clinicopathologic entity?Karen M Doherty, Laura Silveira-Moriyama, Laura Parkkinen, et al.
Journal of Neurogenetics|April 9, 2011
Promotion of sleep by suvorexant-a novel dual orexin receptor antagonistChristopher J Winrow, Anthony L Gotter, Christopher D Cox, et al.
Neuropharmacology|October 25, 2011
Pharmacological characterization of MK-6096 - a dual orexin receptor antagonist for insomniaChristopher J Winrow, Anthony L Gotter, Christopher D Cox, et al.
Neuropharmacology|July 15, 2009
Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposureChristopher J Winrow, Keith Q Tanis, Duane R Reiss, et al.
Frontiers in Neuroscience|January 9, 2014
Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulatorsAndres D Ramirez, Anthony L Gotter, Steven V Fox, et al.
Journal of Neurogenetics|November 19, 2011
Pharmacological validation of candidate causal sleep genes identified in an N2 crossJoseph I Brunner, Anthony L Gotter, Joshua Millstein, et al.
Pageof 10